Nuclear medicine studies of the heart

Myocardial perfusion imaging using a technetium-99m sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosus

INTRODUCTION

The aim of the present study was to evaluate technetium-99m sestamibi single photon emission tomography (SPECT) myocardial perfusion imaging (MPI) and its association with some clinical and laboratory parameters in an asymptomatic systemic lupus erythematosus (SLE) population.

MATERIALS AND METHODS

Twenty-one subjects with SLE and no suspected or documented coronary artery disease (CAD) accomplished myocardial perfusion imaging. Some SLE and CAD parameters were also evaluated in association with myocardial SPECT.

RESULTS

Twenty-one women with a diagnosis of SLE (mean age 36.9 ± 12.8) entered the study. All patients were in the low-risk category for CAD pretest; however, abnormal myocardial perfusion results were found in eight (38%) patients. Amongst the traditional CAD risk factors, there was a significant association between the presence of dyslipidemia and myocardial perfusion abnormalities (P= 0.047). However, we found no significant association between other traditional and SLE-specific risk factors.

CONCLUSION

This study's significant finding was that asymptomatic CAD is common in SLE patients, even in those thought to be low risk for CAD and in the absence of cardiac symptoms.

Defining the success of cardiac gene therapy: how can nuclear imaging contribute?

Gene therapy is a promising modality for the treatment of various cardiovascular diseases such as ischaemia, heart failure, restenosis after revascularisation, hypertension and hyperlipidaemia. An increasing number of approaches are moving from experimental and preclinical validation to clinical application, and several multi-centre trials are currently underway. Despite the rapid progress in cardiac gene therapy, many basic tools and principles remain under development. Questions with regard to the optimal method for gene delivery in a given situation remain open, as do questions concerning therapeutic efficacy and the time course and magnitude of gene expression in target and remote areas. Nuclear imaging provides valuable tools to address these open issues non-invasively. Functional effects of molecular therapy at the tissue level can be identified using tracers of blood flow, metabolism, innervation or cell death. The use of reporter genes and radiolabelled reporter probes allows for non-invasive assessment of location, magnitude and persistence of transgene expression in the heart and the whole body. Co-expression of a reporter gene will allow for indirect imaging of the expression of a therapeutic gene of choice, and linkage of measures of transgene expression to downstream functional effects will enhance the understanding of basic mechanisms of cardiac gene therapy. Hence, nuclear imaging offers great potential to facilitate and refine the determination of therapeutic effects in preclinical and clinical cardiovascular gene therapy.

Angiographic assessment of coronary stenoses: a review of the techniques

This article reviews the fundamental techniques to quantify the physiological severity of (coronary) stenoses. Although a wide survey of different techniques and applications is provided, the focus of this review is on: 1) the assessment of the immediate effect of the stenoses on blood flow (i.e., the hemodynamic severity), and not on the assessment of the pathology of the vessel itself; 2) the flow reserve methods to defining the physiological severity of stenoses; and 3) the determination of blood flow and tissue perfusion by X-ray angiography (a short survey of other imaging modalities is provided as well). Although the practical implementation of the techniques is illustrated by applying them to coronary stenoses, most of the issues involved are of interest in other application areas (using other imaging modalities) as well. This review consists of four parts. The first part deals with the definition of stenoses severity; the second part with tracer kinetic theory necessary to determine flows by imaging; the third part focusses on (cardiac) imaging modalities, with an emphasis on X-ray angiography; and the last part illustrates the practical implementation of the techniques in cardiology.

Signal to noise ratio based filter optimization in triple energy window scatter correction

Triple energy window (TEW) scatter correction estimates the contribution of scattered photons to the acquisition data by acquiring additional data through two narrow energy windows placed adjoined to the main (photopeak) energy window. The contribution is estimated by linear interpolation and then subtracted. Noise amplification is reduced by filtering both the photopeak scintigram and the scatter estimate. We have studied the filter settings of each filter using a physical phantom filled with a 201Tl-solution resulting in count densities comparable to clinical studies. The performance of order-8 Butterworth filters at different cut-off frequencies (CoFs) were compared based on signal to noise ratios (SNRs). The highest SNRs were obtained when the noisy scatter information was strongly filtered with the CoF less than or equal to 0.07 cycles/pixel (cpp). The best CoF for the filter of the photopeak image is object size dependent; smaller objects require a higher CoF. For objects with a size near the SPECT spatial resolution (approximately 15 mm) the optimal CoF is equal to 0.18 cpp. For larger objects (31.8 mm) the highest SNR was obtained with a CoF equal to 0.13 cpp. A CoF equal to 0.16 cpp is a good compromise for all objects with a diameter equal to the spatial resolution or larger. These results depend on the initial signal to noise ratio of the acquisition data and so on the count density.